Indian vaccine manufacturer Serum Institute of India (SII) and its US-based partner Novavax, have announced a regulatory...
US-based Ampio Pharmaceuticals has announced regulatory approval from the Drugs Controller General of India (DCGI) ...
Insightec®, headquarterd in Israel and the US, has announced that its incisionless neurosurgery platform, the Exabla...
At the 9th EAS-EMM (East Asia Summit-Economic Ministers’ Meeting), Anupriya Patel, Minister of State for...
All India Institute of Ayurveda under Ministry of Ayush has signed a MoU in coordination with NICM Western Sydney Univer...
US headquartered TB Alliance has granted Indian pharma firm Lupin, a non-exclusive license to manufacture the anti-TB dr...
Indian firm Biological E. has received Drugs Controller General of India (DCGI) approval for conducting Phase III Compar...
Sher-I-Kashmir Institute Of Medical Sciences (SKIMS) and India Medtronic Private Limited, a wholly owned subsidiary of I...
South Korea-based International Vaccine Institute (IVI) has announced that the first participant has received Indian fir...
Indian firm Gennova Biopharmaceuticals working on the nation's first mRNA-based COVID-19 vaccine, submitted the interim ...
Indian pharma firm Zydus Cadila has received the Emergency Use Authorization (EUA) from the Drug Controller General of I...
Agilent Technologies Inc. has announced that researchers at the Indian Institute of Technology Bombay (IIT-B) ...
Wipro GE Healthcare has launched their first ever GE-SonoSim Simulation Centre Of Excellence (CoE) Lab in the South...
Indian researchers have developed a non-invasive, easy to administer, cost-effective, and patient compliant potential th...
India's Apollo Proton Cancer Centre, the first Proton Therapy Centre in South Asia & the Middle East gets ...
Indian firm Hinduja Group’s business process management entity, Hinduja Global Solutions Limited (HGS) h...
Fusion Antibodies, pre-clinical antibody discovery, and development experts, and BioTickle, their exclusive distributor ...
US-based Novavax, Inc. with its partner, Serum Institute of India (SII), has announced that the companies have filed reg...
